Company: PGEN
Filing Date: 2025-03-19
Form Type: 10-K
Source: 0001356090-25-000007
Chunk: 156

Company: PRECIGEN, INC.
Filing Date: 2025-03-19
Form: 10-K
Item: Item 12
Chunk 156
---
3 

(Amounts in thousands, except share data)20242023Liabilities, Mezzanine Equity and Shareholders' EquityCurrent liabilitiesAccounts payable$3,531 $1,726 Accrued compensation and benefits8,417 8,250 Other accrued liabilities4,812 6,223 Indemnification accrual3,213 5,075 Deferred revenue589 509 Current portion of lease liabilities956 1,202 Total current liabilities21,518 22,985 Deferred revenue, net of current portion1,934 1,818 Lease liabilities, net of current portion4,546 5,895 Deferred tax liabilities— 1,847 Warrant liabilities50,537 — Total liabilities78,535 32,545 Commitments and contingencies (Note 15)Mezzanine EquitySeries A  Preferred Stock, no par value, 81,000 shares and zero shares authorized as of December 31, 2024 and December 31, 2023, respectively; 79,000 shares and zero shares issued as of  December 31, 2024 and December 31, 2023, respectively; aggregate liquidation preference of $79,000 as of December 31, 2024.28,218 — Shareholders' equityCommon stock, no par value, 400,000,000 shares authorized as of December 31, 2024 and 2023; 292,869,097 shares and 256,398,527 shares issued as of December 31, 2024 and 2023, 107,130,903 shares and 248,919,096 shares outstanding as of December 31, 2024 and 2023, respectively.— — Additional paid-in capital2,129,207 2,084,916 Accumulated deficit(2,090,706)(1,964,471)Accumulated other comprehensive income (loss)12 (1,947)Total shareholders' equity38,513 118,498 Total liabilities, mezzanine equity and shareholders' equity$145,266 $151,043 

The accompanying notes are an integral part of these consolidated financial statements.

F-6

Precigen, Inc. and Subsidiaries

Consolidated Statements of Operations

Years Ended December 31, 2024, 2023, and 2022 

(Amount